JDDonline

Explore the Journal of Drugs in Dermatology (JDD), a monthly peer-reviewed, PubMed® indexed dermatology journal & online resource.

Complimentary subscriptions for US dermatologists, dermatology residents, nurse practitioners and physician assistants.

Early Online

CURRENT ISSUE HIGHLIGHTS

Central Centrifugal Cicatricial Alopecia and the Use of Xtressé Nutrient Supplement: A Case Series

Published online October 20, 2026

Central Centrifugal Cicatricial Alopecia (CCCA) is characterized by progressive scarring and hair loss in the vertex or crown of the sc...

read more
Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors

Published online October 20, 2026

Psoriatic arthritis (PsA) is a debilitating inflammatory arthropathy and a major long-term complication of psoriasis, affecting up to 3...

read more
Hidradenitis Suppurativa Increases Risk of Postoperative Complications After Mohs Surgery: A Retrospective Cohort Study

Published online October 15, 2026

To the Editor, Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful nodules, abscesses, and sinus trac...

read more
Q-switched Nd:YAG Laser for Extrafacial Lichen Planus Pigmentosus: A Case Series Highlighting Outcomes and Risks

Published online October 14, 2026

Lichen planus pigmentosus (LPP) is an acquired dermal melanosis that typically affects photo-exposed and flexural surfaces. Q-switched...

read more
Retrospective Review of Dermal Safety Studies of the Organic Sun Filter Bemotrizinol

Published online October 14, 2026

Bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) is a UVA/UVB sun filter that has been approved for use in the European Union sin...

read more
The Current Landscape of Vitiligo Support Groups: An International Survey of Support Group Leaders

Published online October 9, 2026

Vitiligo can significantly impact the quality of life of affected individuals and their family members. Support groups provide numerou...

read more
Celecoxib, Sirolimus, and Acitretin are Associated With Decreased Non-Melanoma Skin Cancer in the General Population

Published online October 8, 2026

Nonmelanoma skin cancer (NMSC) is the most common malignancy in the United States, and a growing public health concern. 1 While a var...

read more
Cicatricial Ectropion in the Setting of IL-13 Inhibition

Published online September 29, 2026

Inhibition of interleukin (IL)-13, a key mediator of type 2 inflammation, is a highly effective and targeted therapeutic strategy for a...

read more

Current Issue

Explore JDDonline
Subscribe to JDD

Discover the latest research, exclusive articles from leading dermatology experts – Subscribe to the JDD today. Complimentary subscriptions available for US dermatologists, dermatology residents, dermatology nurse practitioners & physician assistants.

Subscribe Now

Latest News

Journal of Drugs in Dermatology JDD featuring Injectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case Series

Injectable NASHA Gel Skinbooster for Facial Skin Aging in Premenopausal and Postmenopausal Women With Estrogen Deficiency-Associated Not Receiving Hormone Therapy: A Case Series

| Aesthetics, Featured Articles, Latest News, Women | No Comments
Addressing Estrogen Deficiency Skin Aging: A Non-Hormonal Approach  Here is an insightful new study featured in the JDD! Intrinsic skin aging associated with estrogen deficiency presents a distinct therapeutic challenge…
Journal of Drugs in Dermatology JDD featuring Off-Label Uses of Nemolizumab: A Narrative Review

Off-Label Uses of Nemolizumab: A Narrative Review

| Atopic Dermatitis, Featured Articles, Latest News | No Comments
Beyond AD and PN: Expanding Horizons for Interleukin-31 Blockade in Treatment-Refractory Pruritus  Have you read this article from the JDD? Interleukin-31 receptor alpha targeting has established its place in our…
Journal of Drugs in Dermatology JDD featuring Skincare Mythbusters: The Real Science Behind Benzoyl Peroxide and Sunless Tanners

Skincare Mythbusters: The Real Science Behind Benzoyl Peroxide and Sunless Tanners

| Education, Featured Articles, Latest News, Medical Derm | No Comments
Unpacking clinical data on ingredient safety to separate viral fears from evidence-based facts Some of the most read topics in the JDD archive center on ingredient safety, and we want…

ICYMI: Most Popular Articles From the Summer JDD

| Featured Articles, JDD in the Media, Latest News | No Comments
Leaves are falling and nights are getting longer — fall is here. Even if summer felt like it went by in a blink, it's important not to miss developments in…
Journal of Drugs in Dermatology JDD Editor’s Pick, featuring atopic dermatitis.

JDD October 2026 Highlights and Editor Picks

| Atopic Dermatitis, Featured Articles, JDD Higlights, Latest News | No Comments
Curated by the JDD Editors Missed any of our October highlights? September is our Atopic Dermatitis issue and is packed with intriguing articles, and you’ll want to start to dive…

Discover the Latest: the brand new JDDonline Hair and Scalp Microsite

| Featured Articles, Hair, Latest News | No Comments
Discover the Latest: the brand new JDDonline Hair and Scalp Microsite, supported by KilgourMD. Your ultimate one stop shop for JDD articles, evidence based research, and top resources on the…
View all Derm News

News Topics

JDD Newsletter

Sign up for the JDD eNewsletter for exclusive articles, case reports, Podcast episodes, free CME activities, and more!

Subscribe

JDD Podcast

Journal of Drugs in Dermatology JDD Podcast “Ask the Investigator” spotlight.

Did You Miss These? JDD’s “Ask the Investigator” Podcasts You Can’t Afford to Skip!

| Featured Articles, Featured Podcast, Latest News, The Latest | No Comments
Listen Now! If you’ve been snoozing on the latest JDD "Ask the Investigator" podcast episodes, consider this your wake-up call! Hosted by the ever-insightful Dr. Adam Friedman and sponsored by…
Tune In

Follow Us